BPG is committed to discovery and dissemination of knowledge
Editorial
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Dec 27, 2025; 17(12): 110364
Published online Dec 27, 2025. doi: 10.4240/wjgs.v17.i12.110364
Understanding the prognostic factors affecting survival of patients with primary gastric cancer treated with laparoscopic surgery
Budhi Singh Yadav, Venkata Krishna Vamsi Gade
Budhi Singh Yadav, Venkata Krishna Vamsi Gade, Department of Radiotherapy and Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India
Co-first authors: Budhi Singh Yadav and Venkata Krishna Vamsi Gade.
Author contributions: Yadav BS and Gade VKV contributed to literature review, manuscript writing, editing, final approval, and made equal contribution as co-first authors.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Budhi Singh Yadav, MD, Professor, Department of Radiotherapy and Oncology, Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh 160012, India. drbudhi@gmail.com
Received: June 5, 2025
Revised: June 15, 2025
Accepted: September 3, 2025
Published online: December 27, 2025
Processing time: 203 Days and 13.7 Hours
Abstract

The retrospective study by Gan et al evaluated the three-year survival rate and prognostic factors in 100 patients with primary gastric cancer who underwent laparoscopic surgery at a Chinese hospital between 2019 and 2021. The observed three-year survival rate was 73%. Multivariate analysis identified age, tumor-nodes-metastasis stage, tumor size, depth of invasion, lymph node metastasis, extent of lymph node dissection, postoperative adjuvant chemo-radiotherapy, postoperative carcinoembryonic antigen levels, surgical duration, extent of gastric resection, and postoperative complications as independent predictors of survival. Older age, advanced disease stage, larger tumors, deeper invasion, lymph node involvement, and elevated carcinoembryonic antigen were associated with poorer outcomes, while thorough lymph node dissection and adjuvant therapy improved survival. The study highlights the complex interplay of clinical and pathological factors affecting prognosis after laparoscopic surgery. Strengths include detailed perioperative data and robust analysis, though limitations are noted in its retrospective design and patient selection. The findings emphasize the need for multidisciplinary, individualized treatment planning, considering both disease and patient-related factors, to optimize outcomes in localized gastric cancer. Prospective studies are warranted to validate these results and refine treatment strategies.

Keywords: Gastric cancer; Prognostic factors; Multivariate analysis; Laparoscopic surgery; Survival

Core Tip: Laparoscopic surgery offers a promising three-year survival rate for patients with primary gastric cancer; outcomes are significantly influenced by a range of clinical and pathological factors. The findings underscore the importance of multidisciplinary collaboration to decide the optimal treatment plan for each patient. While making treatment decisions, nutritional status and quality of life should also be taken into consideration in addition to disease- and patient-related features. By identifying key risk factors, the study provides valuable insights for optimizing clinical interventions and improving survival among patients treated with laparoscopic surgery for primary gastric cancer.